The molecular biology of feline immunodeficiency virus (FIV)

Viruses

Volumn 3, Issue 11, 2011, Pages 2192-2213

  Kenyon, Julia C ^a   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

FIV; Lentivirus; Retrovirus

Indexed keywords

CD134 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DOUBLE STRANDED DNA; GAG PROTEIN; GLYCOPROTEIN GP 120; POL PROTEIN; REV PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

CAT DISEASE; DNA SYNTHESIS; DOMESTIC ANIMAL; FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVERSE TRANSCRIPTION; REVIEW; RNA STRUCTURE; STRAIN DIFFERENCE; T LYMPHOCYTE; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV; HIV INFECTIONS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; VIRUS REPLICATION;

EID: 82155191777     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3112192     Document Type: Review

References (144)

1. Pedersen, N.C.; Ho, E.W.; Brown, M.L.; Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987, 235, 790-793.
2. Sparger, E.E.; Luciw, P.A.; Elder, J.H.; Yamamoto, J.K.; Lowenstine, L.J.; Pedersen, N.C. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 1989, 3, S43-S49.
3. Olmsted, R.A.; Langley, R.; Roelke, M.E.; Goeken, R.M.; Adger-Johnson, D.; Goff, J.P.; Albert, J.P.; Packer, C.; Laurenson, M.K.; Caro, T.M.; et al. Worldwide prevalence of lentivirus infection in wild feline species: Epidemiologic and phylogenetic aspects. J. Virol. 1992, 66, 6008-6018.
4. Troyer, J.L.; Pecon-Slattery, J.; Roelke, M.E.; Johnson, W.; VandeWoude, S.; Vazquez-Salat, N.; Brown, M.; Frank, L.; Woodroffe, R.; Winterbach, C.; et al. Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among felidae and hyaenidae species. J. Virol. 2005, 79, 8282-8294.
5. Ackley, C.D.; Yamamoto, J.K.; Levy, N.; Pedersen, N.C.; Cooper, M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 1990, 64, 5652-5655.
6. Yamamoto, J.K.; Hansen, H.; Ho, E.W.; Morishita, T.Y.; Okuda, T.; Sawa, T.R.; Nakamura, R.M.; Pedersen, N.C. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 1989, 194, 213-220.
7. Callanan, J.J.; Thompson, H.; Toth, S.R.; O'Neil, B.; Lawrence, C.E.; Willett, B.; Jarrett, O. Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet. Immunol. Immunopathol. 1992, 35, 3-13.
8. Callanan, J.J.; Jones, B.A.; Irvine, J.; Willett, B.J.; McCandlish, I.A.; Jarrett, O. Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet. Pathol. 1996, 33, 264-272.
9. Biek, R.; Ruth, T.K.; Murphy, K.M.; Anderson, C.R., Jr.; Poss, M. Examining effects of persistent retroviral infection on fitness and pathogen susceptibility in a natural feline host. Can. J. Zool. 2006, 84, 365-373.
10. Roelke, M.E.; Brown, M.A.; Troyer, J.L.; Winterbach, H.; Winterbach, C.; Hemson, G.; Smith, D.; Johnson, R.C.; Pecon-Slattery, J.; Roca, A.L.; et al. Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology 2009, 390, 1-12.
11. Roelke, M.E.; Pecon-Slattery, J.; Taylor, S.; Citino, S.; Brown, E.; Packer, C.; Vandewoude, S.; O'Brien, S.J. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. J. Wildl. Dis. 2006, 42, 234-248.
12. Miller, C.; Bielefeldt-Ohmann, H.; Macmillan, M.; Huitron-Resendiz, S.; Henriksen, S.; Elder, J.; Vandewoude, S. Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet. Immunol. Immunopathol. 2011, 143, 282-291.
13. Shimojima, M.; Miyazawa, T.; Ikeda, Y.; McMonagle, E.L.; Haining, H.; Akashi, H.; Takeuchi, Y.; Hosie, M.J.; Willett, B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 2004, 303, 1192-1195.
14. Reggeti, F.; Ackerley, C.; Bienzle, D. CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells. J. Gen. Virol. 2008, 89, 277-287.
15. Grant, C.K.; Fink, E.A.; Sundstrom, M.; Torbett, B.E.; Elder, J.H. Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 19980-19985.
16. de Parseval, A.; Chatterji, U.; Morris, G.; Sun, P.; Olson, A.J.; Elder, J.H. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat. Struct. Mol. Biol. 2005, 12, 60-66.
17. de Parseval, A.; Grant, C.K.; Sastry, K.J.; Elder, J.H. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): Soluble CD134 activates FIV env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J. Virol. 2006, 80, 3088-3091.
18. Brelot, A.; Heveker, N.; Adema, K.; Hosie, M.J.; Willett, B.; Alizon, M. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J. Virol. 1999, 73, 2576-2586.
19. Willett, B.J.; Adema, K.; Heveker, N.; Brelot, A.; Picard, L.; Alizon, M.; Turner, J.D.; Hoxie, J.A.; Peiper, S.; Neil, J.C.; et al. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J. Virol. 1998, 72, 6475-6481.
20. Hosie, M.J.; Pajek, D.; Samman, A.; Willett, B.J. Feline immunodeficiency virus (FIV) neutralization: A review. Viruses 2011, 3, 1870-1890.
21. Kraase, M.; Sloan, R.; Klein, D.; Logan, N.; McMonagle, L.; Biek, R.; Willett, B.J.; Hosie, M.J. Feline immunodeficiency virus env gene evolution in experimentally infected cats. Vet. Immunol. Immunopathol. 2010, 134, 96-106.
22. Samman, A.; Logan, N.; McMonagle, E.L.; Ishida, T.; Mochizuki, M.; Willett, B.J.; Hosie, M.J. Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of env. J. Gen. Virol. 2010, 91, 242-249.
23. Willett, B.J.; Hosie, M.J. Chemokine receptors and co-stimulatory molecules: Unravelling feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2008, 123, 56-64.
24. English, R.V.; Johnson, C.M.; Gebhard, D.H.; Tompkins, M.B. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 1993, 67, 5175-5186.
25. Dean, G.A.; Reubel, G.H.; Moore, P.F.; Pedersen, N.C. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J. Virol. 1996, 70, 5165-5169.
26. Hosie, M.J.; Willett, B.J.; Klein, D.; Dunsford, T.H.; Cannon, C.; Shimojima, M.; Neil, J.C.; Jarrett, O. Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J. Virol. 2002, 76, 6062-6072.
27. de Parseval, A.; Elder, J.H. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 2001, 75, 4528-4539.
28. Verschoor, E.J.; Boven, L.A.; Blaak, H.; van Vliet, A.L.; Horzinek, M.C.; de Ronde, A. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 1995, 69, 4752-4757.
29. Hu, Q.Y.; Fink, E.; Happer, M.; Elder, J.H. Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J. Virol. 2011, 85, 7108-7117.
30. Bobardt, M.D.; Saphire, A.C.; Hung, H.C.; Yu, X.; Van der Schueren, B.; Zhang, Z.; David, G.; Gallay, P.A. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003, 18, 27-39.
31. Willett, B.J.; McMonagle, E.L.; Logan, N.; Samman, A.; Hosie, M.J. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology 2008, 5, 77.
32. Willett, B.J.; Kraase, M.; Logan, N.; McMonagle, E.L.; Samman, A.; Hosie, M.J. Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody. Retrovirology 2010, 7, 38.
33. Ikeda, Y.; Miyazawa, T.; Nishimura, Y.; Nakamura, K.; Tohya, Y.; Mikami, T. High genetic stability of TM1 and TM2 strains of subtype B feline immunodeficiency virus in long-term infection. J. Vet. Med. Sci. 2004, 66, 287-289.
34. Huisman, W.; Schrauwen, E.J.; Rimmelzwaan, G.F.; Osterhaus, A.D. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus. Virus Res. 2008, 137, 24-32.
35. McEwan, W.A.; McMonagle, E.L.; Logan, N.; Serra, R.C.; Kat, P.; Vandewoude, S.; Hosie, M.J.; Willett, B.J. Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the african lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. J. Virol. 2008, 82, 10953-10958
36. Smirnova, N.; Troyer, J.L.; Schissler, J.; Terwee, J.; Poss, M.; VandeWoude, S. Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements. Virology 2005, 342, 60-76.
37. Arts, E.J.; Stetor, S.R.; Li, X.; Rausch, J.W.; Howard, K.J.; Ehresmann, B.; North, T.W.; Wohrl, B.M.; Goody, R.S.; Wainberg, M.A.; et al. Initiation of (-) strand DNA synthesis from tRNA(3lys) on lentiviral RNAs: Implications of specific HIV-1 RNA-tRNA(3lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 10063-10068.
38. Miller, J.T.; Ehresmann, B.; Hubscher, U.; Le Grice, S.F. A novel interaction of tRNA(lys,3) with the feline immunodeficiency virus RNA genome governs initiation of minus strand DNA synthesis. J. Biol. Chem. 2001, 276, 27721-27730.
39. Arts, E.J.; Le Grice, S.F. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. Prog. Nucleic Acid. Res. Mol. Biol. 1998, 58, 339-393.
40. Whitwam, T.; Peretz, M.; Poeschla, E. Identification of a central DNA flap in feline immunodeficiency virus. J. Virol. 2001, 75, 9407-9414.
41. Zennou, V.; Petit, C.; Guetard, D.; Nerhbass, U.; Montagnier, L.; Charneau, P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101, 173-185.
42. Hu, C.; Saenz, D.T.; Fadel, H.J.; Walker, W.; Peretz, M.; Poeschla, E.M. The HIV-1 central polypurine tract functions as a second line of defense againstAPOBEC3G/F. J. Virol. 2010, 84, 11981-11993.
43. Auwerx, J.; North, T.W.; Preston, B.D.; Klarmann, G.J.; De Clercq, E.; Balzarini, J. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: Role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors. Mol. Pharmacol. 2002, 61, 400-406.
44. Auwerx, J.; Esnouf, R.; De Clercq, E.; Balzarini, J. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. Mol. Pharmacol. 2004, 65, 244-251.
45. North, T.W.; Cronn, R.C.; Remington, K.M.; Tandberg, R.T.; Judd, R.C. Characterization of reverse transcriptase from feline immunodeficiency virus. J. Biol. Chem. 1990, 265, 5121-5128.
46. Operario, D.J.; Reynolds, H.M.; Kim, B. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases. Virology 2005, 335, 106-121.
47. Wagaman, P.C.; Hasselkus-Light, C.S.; Henson, M.; Lerner, D.L.; Phillips, T.R.; Elder, J.H. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology 1993, 196, 451-457.
48. Threadgill, D.S.; Steagall, W.K.; Flaherty, M.T.; Fuller, F.J.; Perry, S.T.; Rushlow, K.E.; Le Grice, S.F.; Payne, S.L. Characterization of equine infectious anemia virus dUTPase: Growth properties of a dUTPase-deficient mutant. J. Virol. 1993, 67, 2592-2600.
49. Lerner, D.L.; Wagaman, P.C.; Phillips, T.R.; Prospero-Garcia, O.; Henriksen, S.J.; Fox, H.S.; Bloom, F.E.; Elder, J.H. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 7480-7484.
50. Prasad, G.S.; Stura, E.A.; McRee, D.E.; Laco, G.S.; Hasselkus-Light, C.; Elder, J.H.; Stout, C.D. Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus. Protein Sci. 1996, 5, 2429-2437.
51. Elder, J.H.; Lerner, D.L.; Hasselkus-Light, C.S.; Fontenot, D.J.; Hunter, E.; Luciw, P.A.; Montelaro, R.C.; Phillips, T.R. Distinct subsets of retroviruses encode dUTPase. J. Virol. 1992, 66, 1791-1794.
52. McGeoch, D.J. Protein sequence comparisons show that the 'pseudoproteases' encoded by poxviruses and certain retroviruses belong to the deoxyuridine triphosphatase family. Nucleic Acids Res. 1990, 18, 4105-4110.
53. McClure, M.A.; Johnson, M.S.; Doolittle, R.F. Relocation of a protease-like gene segment between two retroviruses. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 2693-2697.
54. Kwong, P.D.; Wyatt, R.; Robinson, J.; Sweet, R.W.; Sodroski, J.; Hendrickson, W.A. Structure of an HIV GP120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393, 648-659.
55. Abergel, C.; Robertson, D.L.; Claverie, J.M. Hidden dUTPase sequence in human immunodeficiency virus type 1 gp120. J. Virol. 1999, 73, 751-753.
56. Mansky, L.M.; Preveral, S.; Selig, L.; Benarous, R.; Benichou, S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 2000, 74, 7039-7047.
57. Munk, C.; Beck, T.; Zielonka, J.; Hotz-Wagenblatt, A.; Chareza, S.; Battenberg, M.; Thielebein, J.; Cichutek, K.; Bravo, I.G.; O'Brien, S.J.;x /xet-alet al./et-al Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 2008, 9, R48.
58. Larue, R.S.; Lengyel, J.; Jonsson, S.R.; Andresdottir, V.; Harris, R.S. Lentiviral vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J. Virol. 2010, 84, 8193-8201.
59. Desrosiers, R.C.; Lifson, J.D.; Gibbs, J.S.; Czajak, S.C.; Howe, A.Y.; Arthur, L.O.; Johnson, R.P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 1998, 72, 1431-1437.
60. Shen, X.; Leutenegger, C.M.; Stefano Cole, K.; Pedersen, N.C.; Sparger, E.E. A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens. J. Gen. Virol. 2007, 88, 2793-2799.
61. Busschots, K.; Vercammen, J.; Emiliani, S.; Benarous, R.; Engelborghs, Y.; Christ, F.; Debyser, Z. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 2005, 280, 17841-17847.
62. Poeschla, E.M. Integrase, LEDGF/p75 and HIV replication. Cell Mol. Life Sci. 2008, 65, 1403-1424.
63. Llano, M.; Delgado, S.; Vanegas, M.; Poeschla, E.M. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 2004, 279, 55570-55577.
64. Llano, M.; Vanegas, M.; Fregoso, O.; Saenz, D.; Chung, S.; Peretz, M.; Poeschla, E.M. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 2004, 78, 9524-9537.
65. Krishnan, L.; Matreyek, K.A.; Oztop, I.; Lee, K.; Tipper, C.H.; Li, X.; Dar, M.J.; Kewalramani, V.N.; Engelman, A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84, 397-406.
66. Berthoux, L.; Sebastian, S.; Muesing, M.A.; Luban, J. The role of lysine 186 in HIV-1 integrase multimerization. Virology 2007, 364, 227-236.
67. van den Ent, F.M.; Vos, A.; Plasterk, R.H. Dissecting the role of the n-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis. J. Virol. 1999, 73, 3176-3183.
68. Burke, C.J.; Sanyal, G.; Bruner, M.W.; Ryan, J.A.; LaFemina, R.L.; Robbins, H.L.; Zeft, A.S.; Middaugh, C.R.; Cordingley, M.G. Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase. J. Biol. Chem. 1992, 267, 9639-9644.
69. Bushman, F.D.; Engelman, A.; Palmer, I.; Wingfield, P.; Craigie, R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 3428-3432.
70. Lee, S.P.; Han, M.K. Zinc stimulates Mg2+-dependent 3'-processing activity of human immunodeficiency virus type 1 integrase in vitro. Biochemistry 1996, 35, 3837-3844.
71. Lee, S.P.; Xiao, J.; Knutson, J.R.; Lewis, M.S.; Han, M.K. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 1997, 36, 173-180.
72. Zheng, R.; Jenkins, T.M.; Craigie, R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 13659-13664.
73. Shibagaki, Y.; Holmes, M.L.; Appa, R.S.; Chow, S.A. Characterization of feline immunodeficiency virus integrase and analysis of functional domains. Virology 1997, 230, 1-10.
74. Savarino, A.; Pistello, M.; D'Ostilio, D.; Zabogli, E.; Taglia, F.; Mancini, F.; Ferro, S.; Matteucci, D.; De Luca, L.; Barreca, M.L.; et al. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS. Retrovirology 2007, 4, 79.
75. Shibagaki, Y.; Chow, S.A. Central core domain of retroviral integrase is responsible for target site selection. J. Biol. Chem. 1997, 272, 8361-8369.
76. Vink, C.; van der Linden, K.H.; Plasterk, R.H. Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J. Virol. 1994, 68, 1468-1474.
77. Sparger, E.E.; Shacklett, B.L.; Renshaw-Gegg, L.; Barry, P.A.; Pedersen, N.C.; Elder, J.H.; Luciw, P.A. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 1992, 187, 165-177.
78. Waters, A.K.; De Parseval, A.P.; Lerner, D.L.; Neil, J.C.; Thompson, F.J.; Elder, J.H. Influence of Orf2 on host cell tropism of feline immunodeficiency virus. Virology 1996, 215, 10-16.
79. de Parseval, A.; Elder, J.H. Demonstration that Orf2 encodes the feline immunodeficiency virus transactivating (tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 1999, 73, 608-617.
80. Miyazawa, T.; Fukasawa, M.; Hasegawa, A.; Maki, N.; Ikuta, K.; Takahashi, E.; Hayami, M.; Mikami, T. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. Isolate. J. Virol. 1991, 65, 1572-1577.
81. Olmsted, R.A.; Barnes, A.K.; Yamamoto, J.K.; Hirsch, V.M.; Purcell, R.H.; Johnson, P.R. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 2448-2452.
82. Phillips, T.R.; Talbott, R.L.; Lamont, C.; Muir, S.; Lovelace, K.; Elder, J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 1990, 64, 4605-4613.
83. Talbott, R.L.; Sparger, E.E.; Lovelace, K.M.; Fitch, W.M.; Pedersen, N.C.; Luciw, P.A.; Elder, J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 5743-5747.
84. Ikeda, Y.; Inoshima, Y.; Kawaguchi, Y.; Maeda, K.; Kohmoto, M.; Kai, C.; Miyazawa, T.; Mikami, T. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat. J. Gen. Virol. 1998, 79 95-99.
85. Kawaguchi, Y.; Norimine, J.; Miyazawa, T.; Kai, C.; Mikami, T. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1. Virology 1992, 190, 465-468.
86. Thompson, F.J.; Elder, J.; Neil, J.C. Cis- and trans-regulation of feline immunodeficiency virus: Identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 1994, 75, 545-554.
87. Hess, J.L.; Small, J.A.; Clements, J.E. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: Involvement of AP-1 sites in basal activity and trans-activation. J. Virol. 1989, 63, 3001-3015.
88. Kalinski, H.; Mashiah, P.; Rotem, D.; Orzech, Y.; Sherman, L.; Miki, T.; Yaniv, A.; Gazit, A.; Tronick, S.R. Characterization of cDNAs species encoding the tat protein of caprine arthritis encephalitis virus. Virology 1994, 204, 828-834.
89. Saltarelli, M.J.; Schoborg, R.; Gdovin, S.L.; Clements, J.E. The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication. Virology 1993, 197, 35-44.
90. van 't Wout, A.B.; Lehrman, G.K.; Mikheeva, S.A.; O'Keeffe, G.C.; Katze, M.G.; Bumgarner, R.E.; Geiss, G.K.; Mullins, J.I. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J. Virol. 2003, 77, 1392-1402.
91. Sundstrom, M.; Chatterji, U.; Schaffer, L.; de Rozieres, S.; Elder, J.H. Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology 2008, 371, 394-404.
92. Oberste, M.S.; Greenwood, J.D.; Gonda, M.A. Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus. J. Virol. 1991, 65, 3932-3937.
93. Davis, J.L.; Molineaux, S.; Clements, J.E. Visna virus exhibits a complex transcriptional pattern: One aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus. J. Virol. 1987, 61, 1325-1331.
94. Saltarelli, M.; Querat, G.; Konings, D.A.; Vigne, R.; Clements, J.E. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 1990, 179, 347-364.
95. Malim, M.H.; Bohnlein, S.; Fenrick, R.; Le, S.Y.; Maizel, J.V.; Cullen, B.R. Functional comparison of the rev trans-activators encoded by different primate immunodeficiency virus species. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 8222-8226.
96. Tomonaga, K.; Mikami, T. Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen. Virol. 1996, 77, 1611-1621.
97. Fischer, U.; Huber, J.; Boelens, W.C.; Mattaj, I.W.; Luhrmann, R. The HIV-1 rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82, 475-483.
98. Tomonaga, K.; Miyazawa, T.; Kawaguchi, Y.; Kohmoto, M.; Inoshima, Y.; Mikami, T. Comparison of the rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J. Vet. Med. Sci. 1994, 56, 199-201.
99. Brown, V.M.; Krynetski, E.Y.; Krynetskaia, N.F.; Grieger, D.; Mukatira, S.T.; Murti, K.G.; Slaughter, C.A.; Park, H.W.; Evans, W.E. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress. J. Biol. Chem. 2004, 279, 5984-5992.
100. Mancuso, V.A.; Hope, T.J.; Zhu, L.; Derse, D.; Phillips, T.; Parslow, T.G. Posttranscriptional effector domains in the rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J. Virol. 1994, 68, 1998-2001.
101. Na, H.; Huisman, W.; Ellestad, K.K.; Phillips, T.R.; Power, C. Domain- and nucleotide-specific rev response element regulation of feline immunodeficiency virus production. Virology 2010, 404, 246-260.
102. Lever, A.M. HIV-1 RNA packaging. Adv. Pharmacol. 2007, 55, 1-32.
103. Kemler, I.; Meehan, A.; Poeschla, E.M. Live-cell coimaging of the genomic RNAs and gag proteins of two lentiviruses. J. Virol. 2010, 84, 6352-6366.
104. Browning, M.T.; Mustafa, F.; Schmidt, R.D.; Lew, K.A.; Rizvi, T.A. Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res. 2003, 93, 199-209.
105. Kemler, I.; Barraza, R.; Poeschla, E.M. Mapping the encapsidation determinants of feline immunodeficiency virus. J. Virol. 2002, 76, 11889-11903.
106. Browning, M.T.; Mustafa, F.; Schmidt, R.D.; Lew, K.A.; Rizvi, T.A. Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J. Gen. Virol. 2003, 84, 621-627.
107. Kemler, I.; Azmi, I.; Poeschla, E.M. The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation. Virology 2004, 327, 111-120.
108. Mustafa, F.; Ghazawi, A.; Jayanth, P.; Phillip, P.S.; Ali, J.; Rizvi, T.A. Sequences intervening between the core packaging determinants are dispensable for maintaining the packaging potential and propagation of feline immunodeficiency virus transfer vector RNAs. J. Virol. 2005, 79, 13817-13821.
109. Browning, M.T.; Schmidt, R.D.; Lew, K.A.; Rizvi, T.A. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 2001, 75, 5129-5140.
110. Kenyon, J.C.; Tanner, S.J.; Legiewicz, M.; Phillip, P.S.; Rizvi, T.A.; Le Grice, S.F.; Lever, A.M. SHAPE analysis of the FIV leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res. 2011, 39, 6692-6704.
111. Manrique, M.L.; Rauddi, M.L.; Gonzalez, S.A.; Affranchino, J.L. Functional domains in the feline immunodeficiency virus nucleocapsid protein. Virology 2004, 327, 83-92.
112. Moscardini, M.; Pistello, M.; Bendinelli, M.; Ficheux, D.; Miller, J.T.; Gabus, C.; Le Grice, S.F.; Surewicz, W.K.; Darlix, J.L. Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J. Mol. Biol. 2002, 318, 149-159.
113. Burkala, E.; Poss, M. Evolution of feline immunodeficiency virus gag proteins. Virus Genes 2007, 35, 251-264.
114. Affranchino, J.L.; Gonzalez, S.A. In vitro assembly of the feline immunodeficiency virus gag polyprotein. Virus Res. 2010, 150, 153-157.
115. Manrique, M.L.; Celma, C.C.; Gonzalez, S.A.; Affranchino, J.L. Mutational analysis of the feline immunodeficiency virus matrix protein. Virus Res. 2001, 76, 103-113.
116. Egberink, H.F.; Ederveen, J.; Montelaro, R.C.; Pedersen, N.C.; Horzinek, M.C.; Koolen, M.J. Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J. Gen. Virol. 1990, 71, 739-743.
117. Nath, M.D.; Peterson, D.L. In vitro assembly of feline immunodeficiency virus capsid protein: Biological role of conserved cysteines. Arch. Biochem. Biophys. 2001, 392, 287-294.
118. Gamble, T.R.; Yoo, S.; Vajdos, F.F.; von Schwedler, U.K.; Worthylake, D.K.; Wang, H.; McCutcheon, J.P.; Sundquist, W.I.; Hill, C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278, 849-853.
119. Ganser-Pornillos, B.K.; Cheng, A.; Yeager, M. Structure of full-length HIV-1 CA: A model for the mature capsid lattice. Cell 2007, 131, 70-79.
120. Luttge, B.G.; Freed, E.O. FIV gag: Virus assembly and host-cell interactions. Vet. Immunol. Immunopathol. 2010, 134, 3-13.
121. Manrique, M.L.; Gonzalez, S.A.; Affranchino, J.L. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses. Virology 2004, 329, 157-167.
122. Gonzalez, S.A.; Affranchino, J.L. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the gag precursor. Virology 1998, 240, 27-35.
123. Granowitz, C.; Goff, S.P. Substitution mutations affecting a small region of the moloney murine leukemia virus MA gag protein block assembly and release of virion particles. Virology 1994, 205, 336-344.
124. Luttge, B.G.; Shehu-Xhilaga, M.; Demirov, D.G.; Adamson, C.S.; Soheilian, F.; Nagashima, K.; Stephen, A.G.; Fisher, R.J.; Freed, E.O. Molecular characterization of feline immunodeficiency virus budding. J. Virol. 2008, 82, 2106-2119.
125. Huang, M.; Orenstein, J.M.; Martin, M.A.; Freed, E.O. P6gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995, 69, 6810-6818.
126. Calistri, A.; Del Vecchio, C.; Salata, C.; Celestino, M.; Celegato, M.; Gottlinger, H.; Palu, G.; Parolin, C. Role of the feline immunodeficiency virus l-domain in the presence or absence of gag processing: Involvement of ubiquitin and nedd4-2s ligase in viral egress. J. Cell Physiol. 2009, 218, 175-182.
127. Celma, C.C.; Paladino, M.G.; Gonzalez, S.A.; Affranchino, J.L. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions. Virology 2007, 366, 405-414.
128. Neil, S.J.; Zang, T.; Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 vpu. Nature 2008, 451, 425-430.
129. Gupta, R.K.; Mlcochova, P.; Pelchen-Matthews, A.; Petit, S.J.; Mattiuzzo, G.; Pillay, D.; Takeuchi, Y.; Marsh, M.; Towers, G.J. Simian immunodeficiency virus envelope glycoproteincounteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 20889-20894.
130. Jia, B.; Serra-Moreno, R.; Neidermyer, W.; Rahmberg, A.; Mackey, J.; Fofana, I.B.; Johnson, W.E.; Westmoreland, S.; Evans, D.T. Species-specific activity of SIV nef and HIV-1 vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009, 5, e1000429.
131. Le Tortorec, A.; Neil, S.J. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 2009, 83, 11966-11978.
132. Zhang, F.; Wilson, S.J.; Landford, W.C.; Virgen, B.; Gregory, D.; Johnson, M.C.; Munch, J.; Kirchhoff, F.; Bieniasz, P.D.; Hatziioannou, T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009, 6, 54-67.
133. Dietrich, I.; McMonagle, E.L.; Petit, S.J.; Vijayakrishnan, S.; Logan, N.; Chan, C.N.; Towers, G.J.; Hosie, M.J.; Willett, B.J. Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J. Virol. 2011, 85, 5840-5852.
134. Hong, Y.; Fink, E.; Hu, Q.Y.; Kiosses, W.B.; Elder, J.H. OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J. Virol. 2010, 84, 7225-7232.
135. Elder, J.H.; Schnolzer, M.; Hasselkus-Light, C.S.; Henson, M.; Lerner, D.A.; Phillips, T.R.; Wagaman, P.C.; Kent, S.B. Identification of proteolytic processing sites within the gag and pol polyproteins of feline immunodeficiency virus. J. Virol. 1993, 67, 1869-1876.
136. Pettit, S.C.; Sheng, N.; Tritch, R.; Erickson-Viitanen, S.; Swanstrom, R. The regulation of sequential processing of HIV-1 gag by the viral protease. Adv. Exp. Med. Biol. 1998, 436, 15-25.
137. Lin, Y.C.; Brik, A.; de Parseval, A.; Tam, K.; Torbett, B.E.; Wong, C.H.; Elder, J.H. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. J. Virol. 2006, 80, 7832-7843.
138. Laco, G.S.; Fitzgerald, M.C.; Morris, G.M.; Olson, A.J.; Kent, S.B.; Elder, J.H. Molecular analysis of the feline immunodeficiency virus protease: Generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases. J. Virol. 1997, 71, 5505-5511.
139. Wlodawer, A.; Gustchina, A.; Reshetnikova, L.; Lubkowski, J.; Zdanov, A.; Hui, K.Y.; Angleton, E.L.; Farmerie, W.G.; Goodenow, M.M.; Bhatt, D.;x /xet-alet al/et-al. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nat. Struct. Biol. 1995, 2, 480-488.
140. Laco, G.S.; Schalk-Hihi, C.; Lubkowski, J.; Morris, G.; Zdanov, A.; Olson, A.; Elder, J.H.; Wlodawer, A.; Gustchina, A. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. Biochemistry 1997, 36, 10696-10708.
141. Wlodawer, A.; Gustchina, A. Structural and biochemical studies of retroviral proteases. Biochim. Biophys. Acta 2000, 1477, 16-34.
142. Beck, Z.Q.; Lin, Y.C.; Elder, J.H. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases. J. Virol. 2001, 75, 9458-9469.
143. Stern, M.A.; Hu, C.; Saenz, D.T.; Fadel, H.J.; Sims, O.; Peretz, M.; Poeschla, E.M. Productive replication of vif-chimeric HIV-1 in feline cells. J. Virol. 2010, 84, 7378-7395.
144. Zielonka, J.; Marino, D.; Hofmann, H.; Yuhki, N.; Lochelt, M.; Munk, C. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 2010, 84, 7312-7324.